MyOrbit.tv » Biotech

Business Executives in Pharma Biotech Industry

MyOrbit-Team — Sun, 11 Dec 2011 21:50:52 +0000

Patrick Mahaffy, CEO & Founder, Clovis Oncology
Dan Burgess, CEO & Founder, Rempex Pharmaceuticals
Faheem Hasnain, President & CEO, Receptos
Remi Brouard, Vice President External Innovation, Sanofi-Aventis R&D
Polly Murphy, Vice President, Worldwide Business Development, Pfizer
Mark Noguchi, Gloabl Head of Alliance Management, Roche
Roger Pomerantz, SVP and Head Worldwide Licensing, Merck
Mark Edwards, Managing Director, Bioscience Advisors
George Golumbeski, Senior Vice President Business Development, Celgene Corporation
Kurt Graves, Executive Chairman, Intarcia Therapeutics, Inc.
Natasha Hernday, VP of Corporate Development, Seattle Genetics
Paul Laikind, Chief Business Officer and Senior VP of Business Development, Sanford Burnham Research Institute
Jeremy Levin, Senior Vice President, Strategy, Alliances and Transactions, Bristol-Meyers Squibb
Brian McVeigh, Vice President, WWBD Transactions Investment Management, GlaxoSmithKline Pharmaceuticals
Bob More, General Partner, Frazier Healthcare
Anna Protopapas, SVP Corporate Development and Strategy, Millennium Pharmaceuticals
Melinda Richter, Prescience International
Tony Rosenberg, Head of Global BD & Licensing, Novartis
Jim Schaeffer, Executive Director Worldwide Licensing & External Research, Merck Research Laboratories
Laura Shawver, CEO, Cleave Biosciences
Keith Donnermeyer, Partner, Deloitte & Touche LLP
Luke Evnin, Managing Director, MPM Capital
Andy Schwab, Founder and Managing Partner, 5AM Ventures
Phillipe Tinmouth, Vice President, Business Development & Alliance Management, Vertex Pharmaceuticals, Inc.
Kurt von Emster, Managing Director, venBio LLC
Karen Bernstein, Chairman & Editor-in-Chief, BioCentury
Ben Bonifant, Practice Area Leader, Campbell Alliance

Swine Flu Protection Guide

MyOrbit-Team — Wed, 12 Aug 2009 13:08:19 +0000

Here’s a useful free guide with all the information to understand and combat the swine flu virus, and how to procure Tamiflu rapidly if needed.

http://rocketguides.net/swineflu.html

Feel free to share it with others.

Genetically Modified Foods show Bad Results in Animals

MyOrbit-Team — Wed, 29 Jul 2009 19:31:55 +0000

On May 19th, the American Academy of Environmental Medicine called on “Physicians to educate their patients, the medical community, and the public to avoid GM (genetically modified) foods when possible and provide educational materials concerning GM foods and health risks.

Read the entire article by GMO expert Jeffrey Smith in the PPNF Journal. Join the Price-Pottenger Nutrition Foundation at http://www.ppnf.org .

Also, visit http://www.responsibletechnology.org for more GMO information.

The Business Strategy of Genetically Engineered/Modified Seeds

MyOrbit-Team — Sat, 16 Aug 2008 20:12:56 +0000

Genetically modified seeds can give higher farm yield but they come at a high price because the real cost of the seeds comes from the sustained dependency of the farmer on the seed company. In fact, for the control it gets on the farmers, the seed company could even give the seeds for free.

So the business strategy is very similar to how the printer companies like HP can actually afford to give the printers free, because the actual money comes from the printer cartridge sale.

The main difference is that seeds are much more important for a country’s economy, especially for a country like India with a large base of farmers who depend completely on agricultural income. It is also believed that most domestic seed companies in India are controlled or influenced by the multinational seed company.

A company like Monsanto is just doing its business. They have made investments in R&D and want profits like any other business. The solution lies in having more educated farmers who can make informed decisions about when to use Genetically Engineered/Modified Seeds and when to stick to organic seeds.

Improving biotech status of Hong Kong

MyOrbit-Team — Wed, 03 Oct 2007 09:57:01 +0000

The Hong Kong Jockey Club Institute of Chinese Medicine recently signed a memorandum of understanding (MOU) with Canada’s national food and biotech research institute AFMNet, one of four between Hong Kong and Canadian organisations.

AFMNet Chairman Dr Murray McLaughlin says the MOUs help to develop the research and expertise available on the medicinal benefits of plants, by using Chinese herbal techniques. Co-operation will hasten Hong Kong’s goal to become a regional biotech center. There are also benefits for Hong Kong institutes in using the Canadian synchrotron, the light beam technology that facilitates analysis and diagnostic work across wide industrial and agricultural fields. It could make sense for Hong Kong to develop its own synchrotron, Dr McLaughlin adds.

About this Video: This video has been produced by HKTDC Hong Kong Trade Development Council (www.tdctrade.com), which is the global marketing arm and service hub for Hong Kong-based manufacturers, traders and service exporters, with more than 40 offices worldwide. Thanks to Irene Wong, the Webcast Producer of HKTDC for sharing the video. She can be reached at: tdctrade [at] tdc.org.hk ; MyOrbit will continue to show business update videos of Hong Kong and Asia-Pacific region.

What is MyOrbit.tv

MyOrbit-Team — Thu, 19 Apr 2007 11:28:13 +0000

It’s the first post on this blog. We had maintained a blog on another domain so far, but now merged our blog with the main site, which means all the industry viewpoints and experiences- in text, audio, and video – will be available directly on this site.

MyOrbit.tv is a member-driven Internet video channel focused on business and professional development. Our viewers and members are worldwide, making this an attractive platform to view and share professional experience and promote new products and services – all this at a fraction of current costs involved in marketing, new product launch, and customer interaction.

Of course, this channel won’t solve it all for you, but we have a plan – to add beneficial functionality and information – few at a time, so that a majority of our members can benefit from them. The discussions and videos on this channel are by active professionals and business executives, and we believe it offers great value to our viewers and members. This video shows how you can benefit from this channel.

We will pushing the boundaries of Internet streaming video. Some of the benefits for our Members and Viewers will come from applications like:

Industry discussions and debates with members – this gives original content, which everyone wants to watch.
New product demos by companies (eg. a medical diagnostics company demonstrating the benefits of its new diabetes management product, a SOX consulting company showing their solution framework, etc)
Career Development (eg. sales training and commercial presentation videos, job candidates presenting through video; crash the recruitment process through private videos)
Promoting professionals or new businesses (eg. a warehouse business showcasing its premises, security facilities, and client endorsements)
Pre-approved advertisements (by our Member council) launched by the viewers